New Drug Reviews
Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor
Telaprevir is a hepatitis C NS3/4A protease inhibitor approved by the US Food and Drug Administration as part of combination therapy for the management of chronic hepatitis C virus (HCV) genotype 1 infection.
